Sign In
Buy EYPT
$12.25
-0.610 (-4.74%)
At Close: Jul 31, 2026
Wall Street Analysts Think EyePoint Pharmaceuticals (EYPT) Could Surge 31.27%: Read This Before Placing a Bet
10:56am, Tuesday, 13'th Feb 2024
The consensus price target hints at a 31.3% upside potential for EyePoint Pharmaceuticals (EYPT). While empirical research shows that this sought-after metric is hardly effective, an upward trend in e
EyePoint Pharmaceuticals to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
07:00am, Wednesday, 31'st Jan 2024
WATERTOWN, Mass., Jan. 31, 2024 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing therapeutics to improve the lives of patients w
EyePoint Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference
07:00am, Wednesday, 20'th Dec 2023
WATERTOWN, Mass., Dec. 20, 2023 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing therapeutics to improve the lives of patients w
Huge Warren Buffett Purchase Highlights Hot Insider Buying
09:49am, Saturday, 16'th Dec 2023
From executives to beneficial owners, insiders are increasingly stepping up to the buy window as we approach the end of the year.
EyePoint Pharmaceuticals (EYPT) is a Great Momentum Stock: Should You Buy?
01:32pm, Monday, 11'th Dec 2023
Does EyePoint Pharmaceuticals (EYPT) have what it takes to be a top stock pick for momentum investors? Let's find out.
Wall Street Analysts Believe EyePoint Pharmaceuticals (EYPT) Could Rally 77.05%: Here's is How to Trade
11:16am, Friday, 08'th Dec 2023
The average of price targets set by Wall Street analysts indicates a potential upside of 77.1% in EyePoint Pharmaceuticals (EYPT). While the effectiveness of this highly sought-after metric is questio
What Makes EyePoint Pharmaceuticals (EYPT) a Good Fit for 'Trend Investing'
10:32am, Friday, 08'th Dec 2023
If you are looking for stocks that are well positioned to maintain their recent uptrend, EyePoint Pharmaceuticals (EYPT) could be a great choice. It is one of the several stocks that passed through ou
EyePoint announces $175 million stock offering following record surge in share price
05:06pm, Monday, 04'th Dec 2023
EyePoint Pharmaceuticals Inc. EYPT, +177.46% announced Monday afternoon that it has begun an underwritten public offering of $175 million in common stock. The company will also give underwriters the c
Eyepoint Pharmaceuticals stock soars on wet-AMD trial results
12:52pm, Monday, 04'th Dec 2023
EyePoint Pharmaceuticals Inc (NASDAQ:EYPT) shares surged 176% to $18.24 in midday trading on Monday after the therapeutics developer announced positive results from a Phase 2 trial of its EYP-1901 tre
Why Is EyePoint Pharmaceuticals (EYPT) Stock Up 187% Today?
11:37am, Monday, 04'th Dec 2023
EyePoint Pharmaceuticals (NASDAQ: EYPT ) stock is rocketing higher on Monday thanks to the company's latest clinical trial results for EYP-1901. A Phase 2 clinical trial of EYP-1901 includes positive
EyePoint Pharmaceuticals' stock soars 362% after company announces positive data from trial of wet AMD treatment
07:40am, Monday, 04'th Dec 2023
EyePoint Pharmaceutics Inc.'s stock EYPT, +5.76% rocketed 362% early Monday, after the company announced positive results from a Phase 2 trial of its EYP-1901 treatment for wet age-related macular deg
Small Stakes, Big Rewards: 3 Penny Stocks with 300% Upside Potential
04:17pm, Sunday, 03'rd Dec 2023
If the first rule in the film “Fight Club” is to not talk about fight club, then the same rule applies to penny stocks with potential: you do not talk about these penny stocks with upside. To clar
EyePoint Pharmaceuticals, Inc. (EYPT) Q3 2023 Earnings Conference Call Transcript
01:03pm, Wednesday, 01'st Nov 2023
EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT ) Q3 2023 Earnings Conference Call November 1, 2023 8:30 AM ET Company Participants George Elston - EVP and CFO Jay Duker - President and CEO Conference Cal
EyePoint Pharmaceuticals to Report Third Quarter 2023 Financial Results on November 1, 2023
07:00am, Wednesday, 25'th Oct 2023
WATERTOWN, Mass., Oct. 25, 2023 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing therapeutics to improve the lives of patients w
Why Shares of EyePoint Pharmaceuticals Were Rising Monday
03:20pm, Monday, 11'th Sep 2023
EyePoint reported top-line data on two phase 2 trials for its lead pipeline candidate. The company focuses on serious eye disorders.
